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A concise, asymmetric synthesis of the pentacyclic framework of the cortistatins has been 
accomplished in 12 steps from commercially available starting materials, employing a highly 
diastereoselective intramolecular (4+3) cycloaddition of epoxy enol silanes as the key step.  
The isolation and identification of cortistatin A from the 
marine sponge Corticium simplex in 2006, and subsequently 
its congeners have generated much interest among organic and 
medicinal chemists alike.1  This family of rearranged steroidal 
alkaloids were discovered through a cell anti-proliferation 
assay-guided fractionation, in which cortistatins A (1) and J 
(2) were identified to be the most potent, nanomolar anti-
angiogenic natural products.  With recent data showing that 
anti-angiogenics are generally well-tolerated without 
observable drug resistance, and when given in conjunction 
with traditional cancer drugs could suppress cancer 
recurrence, the discovery and development of new anti-
angiogenics hold promise for future cancer therapy. 
Fig. 1 Cortistatins A and J 
 The bioactivity, therapeutic potential and architectural 
beauty of the cortistatins have inspired many efforts toward 
the synthesis of these molecules in the organic chemistry 
community.2  The isolated quantities being too minute for 
further studies have motivated their semi-, total and formal 
syntheses, as well as quite a number of synthetic studies.4,5  
Successful approaches have enabled the preparation of 
cortistatin derivatives and the assembly of a preliminary SAR 
profile of these compounds.6   
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 The central bicyclic ether in the context of a seven-
membered ring B, a feature of all of the cortistatins, has been 
constructed by diverse approaches, including ring expansions, 
cycloisomerizations, dipolar cycloadditions, RCM, 
cyclizations by radical, alkylation and aldol reactions.4 In 
light of recent communications using cycloadditions to access 
ring B,5 we report herein our efforts in the application of the 
(4+3) cycloaddition of epoxy enol silanes that we have 
developed (Scheme 1),7 to the asymmetric synthesis of these 
molecules.  We proposed to use this reaction in the synthesis 
of cortistatins, not only because both rings B and C could 
conceivably be obtained from this intramolecular (4+3) 
cycloaddition with furan derivatives in a concise manner, but 
also to put this methodology to the test for its compatibility 
and applicability in this context of complex synthetic targets.  
Herein we outline the application of this (4+3) cycloaddition 
to the efficient asymmetric synthesis of 5, the pentacyclic core 
of cortistatins A and J.  
 
Scheme 1 Intramolecular (4+3) cycloaddition of epoxy enol silanes 
 In our synthetic plan, ring D derived from meso 
cyclopentanedione 6 would serve as the linker to unite the 
diene and the dienophile for the key intramolecular (4+3) 
cycloaddition (Scheme 2). Desymmetrization by reduction 
with (S)-CBS-B-Me yielded cyclopentanol (2R,3R)-7a in 94% 
ee and its diastereomer (2S,3R)-7b in 78 % overall yield, 
accompanied by 12% of over-reduced diol.8  Using (S)-CBS-
B-Bu, however, resulted in 7a in comparable yield but with 
only 83% ee.  Protection and addition of furanyllithium 8 to 
7a provided cyclopentanol 9.9  Activation and dehydration of 
the tertiary alcohol yielded cyclopentene 10.  A cross-
metathesis with methyl vinyl ketone mediated by the 
Hoveyda-Grubbs catalyst10 yielded the desired enone 11 
without ring-opening of the cyclopentene.  Chemoselective 
asymmetric epoxidation of the enone in the presence of the 
cyclopentene in 11 employing Deng’s cinchona-derived 
catalyst 12 was achieved in 96% yield to give 13 as a single 
diastereomer having the correct stereochemistry to direct the 
subsequent cycloaddition reaction.11  Conversion to the enol 
silane yielded the requisite cycloaddition precursor 14.  
Gratifyingly, the key (4+3) cycloaddition catalyzed by 
TESOTf afforded the desired cycloadduct 15 having rings B, 
C, and D, in 87% yield as a single diastereomer.   
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 Dehydration of 15 generated enone 16, which was 
subjected to treatment with acid to give diol 17.  The C17 
hydroxyl group was deprotected at this point so that it could 
direct the subsequent reduction to set the stereochemistry of 
ring D.  Using Crabtree’s catalyst, reduction occurred on the 
α-face as desired to afford diol 18 in good yield, along with 
concomitant reduction of the dihydrofuran.  The bis-oxidation 
of diol 18 with Dess-Martin periodinane afforded the expected 
ketoaldehyde, whch spontaneously underwent intramolecular  
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Scheme 2 Asymmetric synthesis of pentacyclic 5 
aldol cyclization upon silica gel chromatography, to afford 5 
in 84% overall yield. 
 In this communication, we report a succinct synthesis of the 
pentacyclic core of 1 and 2 in optically enriched form, in 12 
steps from commercially available substrates, using the 
intramolecular (4+3) cycloaddition of epoxy enol silanes as 
the key step.  The successful application of this reaction to 
synthesize 5 demonstrates the power of this cycloaddition and 
its compatibility with various functional groups for use in 
complex natural product synthesis.  The synthetic strategy 
enabled by this reaction gives us access to differently 
functionalized cortistatin analogues complementary to those 
obtained using previous approaches.  We are currently 
examining the use of an amine-substituted derivative of 
furanyllithium 8 for a more convergent synthesis.  Our 
continuing studies on the total synthesis of the cortistatins and 
their analogues will be reported in due course. 
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